Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulation, Part V: probiotics.

Susan Givens Bell1

  • 1All Children's Hospital, Saint Petersburg, Florida, USA.

Neonatal Network : NN
|February 9, 2007
PubMed
Summary
This summary is machine-generated.

Researchers are exploring new ways to prevent and treat infections in newborns. While some treatments like probiotics show promise, robust clinical trials are needed for definitive answers on agents like pentoxifylline and G-CSF.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Enteral Iron Supplementation.

Neonatal network : NN·2026
Same author

Ondansetron: A Novel Treatment to Reduce the Severity of Neonatal Opioid Withdrawal Syndrome?

Neonatal network : NN·2025
Same author

Second-Line Medications for Neonatal Opioid Withdrawal Syndrome/Neonatal Abstinence Syndrome.

Neonatal network : NN·2025
Same author

The Evidence-Based Practice Process Steps 4, 5, and 6: Integration, Evaluation, and Dissemination.

Neonatal network : NN·2024
Same author

Step 3: Critical Appraisal of Evidence-Expert Opinion.

Neonatal network : NN·2024
Same author

Step 3: Critically Appraising Evidence: Case-Control Studies.

Neonatal network : NN·2023
Same journal

A Quality Improvement Project to Increase Breastfeeding Rates in the NICU.

Neonatal network : NN·2026
Same journal

Parental Advocacy in the NICU: A Unique Case of Infant Hypoglycemia Highlighting the Role of the Family in Improving Outcomes.

Neonatal network : NN·2026
Same journal

Enjoyment in Preterm Infants: Exploring Clinical and Research Perspectives in the Neonatal Intensive Care Unit.

Neonatal network : NN·2026
Same journal

Building the Future Neonatal Nurse Practitioner Workforce: Reviewing Barriers and Strategies to Enrollment.

Neonatal network : NN·2026
Same journal

What Does It Mean to Be a Professional?

Neonatal network : NN·2026
See all related articles

Area of Science:

  • Neonatal pharmacology
  • Immunomodulation in neonates
  • Infectious disease prevention and treatment

Background:

  • Neonates are highly susceptible to infectious processes.
  • Developing effective immunomodulatory strategies for neonates is crucial.
  • Existing treatments for neonatal sepsis have limitations.

Purpose of the Study:

  • To review current research on agents investigated for preventing and treating neonatal infections.
  • To assess the evidence for specific immunomodulatory agents in neonatal care.
  • To identify promising therapeutic avenues and highlight areas needing further investigation.

Main Methods:

  • Review of existing literature on immunomodulatory agents.
  • Analysis of findings from randomized clinical trials.

Related Experiment Videos

  • Evaluation of evidence for pentoxifylline, G-CSF, IVIG, glutamine, and probiotics.
  • Discussion of ongoing and pending clinical trials.

    • Main Results:

    • Pentoxifylline shows potential but lacks large-scale trial data.
    • Granulocyte-colony stimulating factor (G-CSF) lacks clear evidence for sepsis prevention or treatment; trial results are pending.
    • Intravenous immunoglobulin (IVIG) is not effective for sepsis prevention, and its treatment efficacy is uncertain; awaiting study results.
    • Glutamine supplementation did not impact infection rates or necrotizing enterocolitis (NEC) in very low birth weight infants.
    • Probiotics demonstrate promise based on available trial data.

    Conclusions:

    • Several agents are under investigation for neonatal immunomodulation, with varying levels of evidence.
    • Probiotics and potentially pentoxifylline show promise, but require further rigorous clinical validation.
    • Hand hygiene remains the most critical tool for preventing neonatal infections.